An open-label , 2-period crossover study compared the pharmacokinetics of 2 doses of RAL given at 400 mg every 12 hours ( that mimics a bid administration ) by swallowing with 1 dose of 800 mg ( that mimics a qd administration ) by chewing the tablets in 12 healthy volunteers .